Picture Archiving and Communication Systems (PACS) have fundamentally transformed how medical imaging is stored, accessed, and shared across healthcare institutions. In the context of multidisciplinary tumor boards (MTBs) and complex case reviews, PACS serve as the digital backbone that enables seamless collaboration among diverse specialists. The ability to instantly retrieve high-resolution images, compare historical studies, and share findings in real time has elevated the quality of discussions and accelerated the development of personalized treatment plans. As cancer care becomes increasingly collaborative and data-driven, the role of PACS in supporting these multidisciplinary teams has never been more critical.

Understanding PACS in Modern Healthcare

PACS are integrated digital systems designed to capture, store, manage, and distribute medical images from various modalities, including X-ray, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, nuclear medicine, and digital pathology. By replacing traditional film-based archives, PACS offer a centralized repository that can be accessed from any authorized workstation within the healthcare network. The technology typically comprises four main components: image acquisition devices, a secure networking infrastructure, a storage archive (often using DICOM standards), and display workstations equipped with advanced viewing software.

The evolution of PACS over the past three decades has moved from departmental solutions to enterprise-wide platforms that integrate with electronic health records (EHRs), radiology information systems (RIS), and laboratory information systems (LIS). Modern PACS also support vendor-neutral archives (VNAs) and cloud-based deployments, enabling data portability and disaster recovery. In the setting of tumor boards, these capabilities are essential because they allow oncologists, surgeons, pathologists, radiologists, and other specialists to access the same comprehensive set of images and reports without delay.

The Role of PACS in Multidisciplinary Tumor Boards

Multidisciplinary tumor boards bring together specialists from different disciplines to review complex cancer cases, agree on diagnoses, and recommend evidence-based treatment strategies. Historically, these meetings relied on physical film jackets or printed images, which were cumbersome to share and limited the ability to perform side-by-side comparisons. PACS have eliminated these barriers by providing a single digital platform where all relevant imaging data can be loaded, annotated, and discussed in real time.

Enhanced Collaboration Across Specialties

One of the most significant contributions of PACS is the ability to support simultaneous viewing of medical images by multiple participants, regardless of their physical location. During a tumor board session, the radiologist can scroll through a CT scan while the surgeon points out specific anatomical landmarks using electronic tools. The pathologist can overlay digital whole-slide images, and the medical oncologist can reference prior treatment response scans—all from the same PACS interface. This synchronous collaboration reduces the time spent on transferring data and allows the team to focus on clinical decision-making.

Moreover, PACS enable remote participation through secure web-based portals or dedicated thin-client applications. Specialists who cannot attend in person can still view images in real time, contribute to discussions, and save annotations for later review. This flexibility is particularly valuable in large healthcare systems with multiple campuses or in rural settings where access to subspecialists is limited. By removing geographic constraints, PACS expand the pool of expertise available for complex case evaluations.

Real-Time Image Sharing and Telemedicine

The integration of PACS with telemedicine platforms has further enhanced the reach of tumor boards. With secure, encrypted connections, referring physicians and consulting experts can access imaging studies from outside the hospital network. In many institutions, tumor board meetings are now conducted via video conferencing, with the PACS workstation as the primary visual tool. The moderator can control the display, zoom into regions of interest, and even perform three-dimensional reconstructions that help the team understand spatial relationships of tumors.

This real-time sharing capability also supports ad hoc consultations between tumor board sessions. When a surgeon encounters an unexpected finding during an operation, they can request an immediate review of the patient’s images through the PACS, often linked to the mobile viewing platform. Such rapid access reduces the likelihood of incomplete information influencing clinical decisions and helps maintain the continuity of care.

Integration with Electronic Health Records and Clinical Decision Support

Modern PACS are increasingly integrated with EHRs, allowing imaging reports and key images to be linked directly to the patient’s clinical record. During a tumor board, team members can pull up not only the radiology images but also pathology reports, genetic testing results, and medication histories from within the same workflow. Some advanced systems even incorporate clinical decision support (CDS) tools that analyze imaging features and suggest appropriate next steps based on guidelines. This holistic view minimizes the risk of overlooking critical data and ensures that every specialist has a complete picture before contributing to the treatment plan.

Supporting Case Reviews with PACS

Beyond the structured meetings of tumor boards, PACS play a vital role in ongoing case reviews, second-opinion consultations, and quality assurance activities. In academic medical centers, case reviews often involve multiple attending physicians and trainees examining a series of studies to reach a consensus or to teach diagnostic reasoning. PACS enable efficient navigation through large datasets, with tools for tiling, comparison, and synchronization of image sequences.

Historical Data Retrieval and Longitudinal Comparison

One of the most powerful features of PACS is the ability to retrieve historical imaging studies quickly. For patients with chronic or recurrent malignancies, the ability to compare current scans with prior ones is crucial for assessing treatment response, detecting recurrence, or identifying new lesions. In case reviews, the PACS can automatically preload prior studies from the same patient across different modalities. The system can also perform automated registration to align images from different time points, making subtle changes more apparent.

Longitudinal comparison is especially important in oncology, where imaging biomarkers such as tumor size, metabolic activity, and enhancement patterns guide therapeutic decisions. PACS allow clinicians to quickly flip between baseline and follow-up scans, often using split-screen or overlay modes. This capability not only improves diagnostic accuracy but also saves time during tumor board meetings, where dozens of cases may be reviewed in a single session.

Advanced Visualization and Post-Processing

PACS are no longer limited to simple 2D viewing. Advanced workstations offer three-dimensional reconstructions, multiplanar reformatting, and volume rendering that help specialists visualize complex anatomy. In tumor boards, these tools are especially valuable for surgical planning, radiation therapy target delineation, and assessing vascular involvement. For instance, a liver surgeon can use a PACS-generated 3D model to evaluate the relationship between a tumor and major vessels, while the radiation oncologist can fuse PET and CT images to precisely outline the treatment volume.

Some PACS also incorporate artificial intelligence (AI) algorithms that flag suspicious lesions, quantify tumor burden, or calculate standardized uptake values (SUVs). These AI outputs can be displayed alongside the original images, providing decision support that enhances the team’s confidence in their conclusions. As AI continues to evolve, its integration into PACS workflows will likely become a standard feature in tumor board settings.

Key Benefits of PACS in Tumor Board Settings

  • Faster access to imaging data: PACS eliminate the delays associated with retrieving physical films or loading CDs, making images available instantly during tumor board discussions. This speed is critical when decisions need to be made rapidly, such as in acute settings or for time-sensitive treatment windows.
  • Enhanced image quality for better diagnosis: Digital images displayed on calibrated medical-grade monitors offer superior contrast and resolution compared to printed films. Fine details, such as subtle calcifications or enhancement patterns, become more visible, reducing the chance of missed findings.
  • Facilitates remote consultations and telemedicine: PACS enable specialists to participate from anywhere, expanding the expertise available for complex cases. Rural hospitals can connect with tertiary care centers, and international experts can be consulted without travel.
  • Supports multidisciplinary collaboration: By providing a shared visual language, PACS help bridge the communication gaps between different specialties. Radiologists can annotate images to highlight pathology, surgeons can draw proposed incision lines, and pathologists can correlate imaging with histology.
  • Reduces errors and improves patient safety: PACS reduce the risk of lost or mislabeled images, ensure that all relevant studies are available, and often include double‑reading or discrepancy‑identification features. Fewer errors in interpretation or communication lead to safer treatment recommendations.
  • Improves audit trails and documentation: Many PACS log every access and annotation, creating a transparent record of who viewed what and when. This audit trail is valuable for quality improvement, research, and medicolegal purposes.
  • Enables educational opportunities: Tumor board sessions often serve as teaching forums for residents and fellows. PACS allow attendees to review cases independently after the meeting, bookmarking key images for self‑study or for use in lectures.

Technical Considerations and Integration Challenges

Despite the clear advantages, implementing and maintaining a PACS that truly supports tumor boards involves several technical and organizational challenges. Healthcare institutions must address issues related to interoperability, data security, and workflow integration to ensure the system delivers its full potential.

Interoperability and Standardization

One of the primary hurdles is achieving seamless interoperability between PACS from different vendors and other hospital information systems. While the DICOM standard is widely adopted for image exchange, integrating with EHRs, RIS, and pathology systems often requires additional interfaces or intermediary platforms such as vendor-neutral archives. Without proper integration, tumor board participants may have to toggle between multiple applications, which slows down discussions and increases the risk of information gaps.

Healthcare organizations are increasingly adopting HL7 FHIR (Fast Healthcare Interoperability Resources) standards to enable smoother data exchange. PACS that support FHIR can pull structured reports, lab results, and clinical notes directly into the imaging workflow. Institutions investing in enterprise imaging strategies often prioritize platforms that offer robust APIs and support for cloud-based deployments.

Data Security and Privacy

Because tumor boards often involve sharing sensitive patient information across networks and even across institutions, data security is paramount. PACS must comply with regulations such as HIPAA in the United States and GDPR in Europe. Features like role‑based access controls, end‑to‑end encryption, and detailed audit logs are essential. When enabling remote access for external consultants, virtual private networks (VPNs) or secure web portals with multi‑factor authentication should be used.

Another concern is the storage and retention of large volumes of imaging data. As studies become higher resolution and include 3D or tomosynthesis datasets, storage requirements grow exponentially. Cloud PACS offer scalability and disaster recovery, but they also raise questions about data sovereignty and transmission latency. Organizations must carefully balance accessibility with privacy and cost.

Workflow and User Adoption

The success of a PACS in supporting tumor boards ultimately depends on its acceptance by the clinical staff. If the system is too slow, difficult to navigate, or requires excessive clicks to retrieve studies, specialists may revert to less efficient alternatives. Training and ongoing support are crucial to ensure that users are comfortable with advanced features such as image annotation, measurement tools, and sharing capabilities.

Workflow integration also involves the logistics of tumor board preparation. Some PACS allow meeting moderators to pre‑select relevant studies and arrange them in a playlist, which streamlines the presentation. Integration with scheduling systems can automatically link upcoming tumor board meetings with the appropriate patient list and imaging studies.

Future Directions: AI, Cloud, and Expanded Access

The future of PACS in multidisciplinary tumor boards is closely tied to advancements in artificial intelligence, cloud computing, and telemedicine. AI algorithms are already being deployed to assist with image interpretation, but their role in tumor boards is expanding. For example, AI can pre‑screen imaging studies and flag cases that require urgent review, or it can automatically segment tumors and calculate volumetric measurements before the meeting. This pre‑processing reduces the manual workload for radiologists and allows the team to focus on nuanced decision‑making.

Cloud‑based PACS are increasingly popular because they reduce the need for on‑premises hardware and simplify data sharing between institutions. Cloud platforms also enable AI services to be integrated as plug‑ins, making advanced analytics more accessible. However, latency issues in real‑time viewing and concerns about data security remain barriers that vendors are actively addressing through edge computing and improved encryption.

Another trend is the incorporation of augmented reality (AR) and virtual reality (VR) into PACS. Surgeons can use AR overlays during tumor board presentations to simulate a procedure, while VR can create immersive 3D environments for team‑based review of complex cases. Though still in early stages, these technologies have the potential to further enhance spatial understanding and collaboration.

Finally, the push toward value‑based care and personalized medicine will strengthen the role of PACS as a central hub for imaging data. Integration with genomics and other biomarker databases will allow tumor boards to correlate imaging phenotypes with molecular profiles, leading to more tailored treatment strategies. As these datasets grow, PACS will need to handle not just images but also associated quantitative features, annotations, and machine‑learning outputs.

Conclusion

PACS have become an indispensable tool for multidisciplinary tumor boards and case reviews in modern oncology. By enabling rapid access to high‑quality images, supporting real‑time collaboration across distances, and integrating with other clinical systems, PACS help ensure that every specialist has the complete picture needed to make informed decisions. The benefits—ranging from faster turnaround times and improved diagnostic accuracy to enhanced educational opportunities and patient safety—are well documented. As technology continues to evolve, the integration of AI, cloud platforms, and advanced visualization will only deepen the impact of PACS on multidisciplinary cancer care. Healthcare organizations that invest in robust, interoperable PACS are better positioned to deliver the coordinated, evidence‑based treatment that patients deserve.